Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
2(14%)
Results Posted
50%(3 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_1
1
7%
Ph not_applicable
12
86%
Ph phase_3
1
7%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
1(7.1%)
Phase 3Large-scale testing
1(7.1%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

14

all time

Status Distribution
Active(2)
Completed(6)
Terminated(3)
Other(3)

Detailed Status

Completed6
unknown3
Terminated2
Withdrawn1
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
2
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (7.1%)
Phase 31 (7.1%)
N/A12 (85.7%)

Trials by Status

completed643%
withdrawn17%
unknown321%
terminated214%
recruiting17%
active_not_recruiting17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DEVICE
Total Trials
14